Transmedics Group IncTMDX
Price$83.45Intrinsic value$46.3844% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $46.38median of 4 methods · middle span $20-$72based on filings through 30 Jun 2026
Market Price $83.45Price as of 30 Sep 2026
Margin of Safety -44.4%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: -14.6% (near-term consensus, capped) · years 2–5: -12.3%/yr (balance of the path).-12.8% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 6-9.3%Yr 7-6.2%Yr 8-3.1%Yr 9-0.1%Yr 103.0%
-12.3% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 12.1%
Volatility vs market (adjusted beta)1.60

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetTransmedics Group IncTMDXHealth Care
Valuation
P/E21.6×
P/S4.5×
P/B6.1×
EV / Revenue4.5×
EV / EBITDA—
Profitability
Gross margin59.9%
Operating margin17.9%
Net margin22.7%
FCF margin11.8%
Returns
ROE29.3%
ROA10.4%
ROIC30.3%
Growth
Revenue growth (YoY)51.4%
5-yr fwd EPS growth-12.8%
Financial strength
Debt / Equity0.92×
Current ratio6.62×
Altman Z-Score2.8
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.